Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients
BackgroundThe aim of the study is to assess the effect of chronic lung disease on mortality in patients hospitalized with the diagnosis of prevariant COVID-19 Pneumonia compared to patients without chronic lung disease.Research design and methodsA cohort of 1,549 patients admitted to the pandemic cl...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-10-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.957598/full |
| _version_ | 1811343056066052096 |
|---|---|
| author | Hatice Kilic Emine Arguder Aysegul Karalezli Ebru Unsal Rahmet Guner Bircan Kayaslan İmran Hasanoglu İhsan Ates Musa Civak Esmehan Akpınar Ebru Parlak Filiz Sadi Yasin Kocaman Sibel Günay Esra Metan Mukremin Er Aynil Dalkıran Habibe Hezer Hülya Ergüden Zeynep Hancıoğlu Ayşe Kalem Fatma Eser Adalet Aypak Esragül Akıncı Selma Karahmetoğlu Emin Gemcioglu Emra Kalkan Osman İnan Abdulrezzak Yilmaz Bagdagul Güler Esra Çopuroğlu İşil Turan Derya Gökmen Serhat Hayme Aziz Ahmet Surel |
| author_facet | Hatice Kilic Emine Arguder Aysegul Karalezli Ebru Unsal Rahmet Guner Bircan Kayaslan İmran Hasanoglu İhsan Ates Musa Civak Esmehan Akpınar Ebru Parlak Filiz Sadi Yasin Kocaman Sibel Günay Esra Metan Mukremin Er Aynil Dalkıran Habibe Hezer Hülya Ergüden Zeynep Hancıoğlu Ayşe Kalem Fatma Eser Adalet Aypak Esragül Akıncı Selma Karahmetoğlu Emin Gemcioglu Emra Kalkan Osman İnan Abdulrezzak Yilmaz Bagdagul Güler Esra Çopuroğlu İşil Turan Derya Gökmen Serhat Hayme Aziz Ahmet Surel |
| author_sort | Hatice Kilic |
| collection | DOAJ |
| description | BackgroundThe aim of the study is to assess the effect of chronic lung disease on mortality in patients hospitalized with the diagnosis of prevariant COVID-19 Pneumonia compared to patients without chronic lung disease.Research design and methodsA cohort of 1,549 patients admitted to the pandemic clinic with a COVID-19 Pneumonia diagnosis was analyzed. Group 1 and Group 2 were compared in terms of the treatment they received, admission to intensive care, mortality and follow-up parameters.ResultsThe patient group with COVID-19 and lung disease consisted of 231 participants (14.91%) (Group 1). The patient group with COVID-19 but without lung disease had 1,318 participants (85.19%). Group 1 cases were found to receive more oxygen therapy and mechanical ventilation than Group 2 cases (p ≤ 0.001), Following univariate and multiple logistic regression analyses, it was determined that patients with chronic lung disease had a 25.76% higher mortality risk [OR: 25.763, 95% CI (Lower-Upper) (2.445–271.465), p = 0.007].ConclusionIt was found that chronic lung disease contributed significantly to mortality in this study. Among chronic lung diseases, Chronic Obstructive Pulmonary Disease (COPD), lung cancer and interstitial lung diseases (ILDs) were shown to be more effective than other chronic lung diseases in patients with prevariant COVİD-19 population. |
| first_indexed | 2024-04-13T19:22:57Z |
| format | Article |
| id | doaj.art-f1e64985467c4a5bbaf6b36186be32b3 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-04-13T19:22:57Z |
| publishDate | 2022-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-f1e64985467c4a5bbaf6b36186be32b32022-12-22T02:33:29ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-10-01910.3389/fmed.2022.957598957598Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patientsHatice Kilic0Emine Arguder1Aysegul Karalezli2Ebru Unsal3Rahmet Guner4Bircan Kayaslan5İmran Hasanoglu6İhsan Ates7Musa Civak8Esmehan Akpınar9Ebru Parlak10Filiz Sadi11Yasin Kocaman12Sibel Günay13Esra Metan14Mukremin Er15Aynil Dalkıran16Habibe Hezer17Hülya Ergüden18Zeynep Hancıoğlu19Ayşe Kalem20Fatma Eser21Adalet Aypak22Esragül Akıncı23Selma Karahmetoğlu24Emin Gemcioglu25Emra Kalkan26Osman İnan27Abdulrezzak Yilmaz28Bagdagul Güler29Esra Çopuroğlu30İşil Turan31Derya Gökmen32Serhat Hayme33Aziz Ahmet Surel34Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Internal Medicine Disease, Faculty of Medicine, Ankara University of Health Science, Ankara City Hospital, Ankara, TurkeyDepartment of Internal Medicine Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Chest Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, TurkeyDepartment of Infectious Disease, Faculty of Medicine, University of Health Science, Ankara, TurkeyDepartment of Infectious Disease, Faculty of Medicine, University of Health Science, Ankara, TurkeyDepartment of Internal Medicine Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Internal Medicine Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Internal Medicine Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Internal Medicine Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Internal Medicine Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Internal Medicine Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Internal Medicine Diseases, Ankara City Hospital, Ankara, TurkeyDepartment of Anesthesia, Ankara City Hospital, Ankara, TurkeyDepartment of Biostatistics, School of Medicine, Ankara University, Ankara, TurkeyDepartment of Biostatistics, School of Medicine, Ankara University, Ankara, TurkeyDepartment of General Surgery, Ankara City Hospital, Ankara, TurkeyBackgroundThe aim of the study is to assess the effect of chronic lung disease on mortality in patients hospitalized with the diagnosis of prevariant COVID-19 Pneumonia compared to patients without chronic lung disease.Research design and methodsA cohort of 1,549 patients admitted to the pandemic clinic with a COVID-19 Pneumonia diagnosis was analyzed. Group 1 and Group 2 were compared in terms of the treatment they received, admission to intensive care, mortality and follow-up parameters.ResultsThe patient group with COVID-19 and lung disease consisted of 231 participants (14.91%) (Group 1). The patient group with COVID-19 but without lung disease had 1,318 participants (85.19%). Group 1 cases were found to receive more oxygen therapy and mechanical ventilation than Group 2 cases (p ≤ 0.001), Following univariate and multiple logistic regression analyses, it was determined that patients with chronic lung disease had a 25.76% higher mortality risk [OR: 25.763, 95% CI (Lower-Upper) (2.445–271.465), p = 0.007].ConclusionIt was found that chronic lung disease contributed significantly to mortality in this study. Among chronic lung diseases, Chronic Obstructive Pulmonary Disease (COPD), lung cancer and interstitial lung diseases (ILDs) were shown to be more effective than other chronic lung diseases in patients with prevariant COVİD-19 population.https://www.frontiersin.org/articles/10.3389/fmed.2022.957598/fullCOVID-19lungchronicmortalityCOPDlung cancer |
| spellingShingle | Hatice Kilic Emine Arguder Aysegul Karalezli Ebru Unsal Rahmet Guner Bircan Kayaslan İmran Hasanoglu İhsan Ates Musa Civak Esmehan Akpınar Ebru Parlak Filiz Sadi Yasin Kocaman Sibel Günay Esra Metan Mukremin Er Aynil Dalkıran Habibe Hezer Hülya Ergüden Zeynep Hancıoğlu Ayşe Kalem Fatma Eser Adalet Aypak Esragül Akıncı Selma Karahmetoğlu Emin Gemcioglu Emra Kalkan Osman İnan Abdulrezzak Yilmaz Bagdagul Güler Esra Çopuroğlu İşil Turan Derya Gökmen Serhat Hayme Aziz Ahmet Surel Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients Frontiers in Medicine COVID-19 lung chronic mortality COPD lung cancer |
| title | Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients |
| title_full | Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients |
| title_fullStr | Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients |
| title_full_unstemmed | Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients |
| title_short | Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients |
| title_sort | effect of chronic lung diseases on mortality of prevariant covid 19 pneumonia patients |
| topic | COVID-19 lung chronic mortality COPD lung cancer |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2022.957598/full |
| work_keys_str_mv | AT haticekilic effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT eminearguder effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT aysegulkaralezli effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT ebruunsal effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT rahmetguner effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT bircankayaslan effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT imranhasanoglu effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT ihsanates effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT musacivak effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT esmehanakpınar effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT ebruparlak effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT filizsadi effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT yasinkocaman effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT sibelgunay effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT esrametan effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT mukreminer effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT aynildalkıran effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT habibehezer effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT hulyaerguden effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT zeynephancıoglu effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT aysekalem effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT fatmaeser effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT adaletaypak effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT esragulakıncı effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT selmakarahmetoglu effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT emingemcioglu effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT emrakalkan effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT osmaninan effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT abdulrezzakyilmaz effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT bagdagulguler effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT esracopuroglu effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT isilturan effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT deryagokmen effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT serhathayme effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients AT azizahmetsurel effectofchroniclungdiseasesonmortalityofprevariantcovid19pneumoniapatients |